ATTU News Alert Attunity Ltd (ATTU) 9.93 02/14/2015 19:25:28

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Attunity Ltd (ATTU) 9.93 $ATTU

Zacks Rank #5 Additions for Monday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Monday
AR: 40.34 (+0.69), AHH: 10.75 (-0.02), BTE: 19.27 (+0.32), ACI: 1.19 (+0.02), ATTU: 9.93 (+0.05)

What Makes Attunity (ATTU) a Strong Sell? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 7:51AM CST
Attunity is a stock to drop as it has witnessed negative trend in earnings estimate revisions and has seen its price decline significantly.
CHGG: 6.44 (-0.06), ATTU: 9.93 (+0.05)

Attunity Maestro Included in Leading Research Firm's Application Release Automation (ARA) Report
PR Newswire - Mon Feb 09, 6:00AM CST
Attunity Ltd. (NASDAQ CM: ATTU), a leading provider of information availability software solutions, announced today that its management solution for application release automation (ARA), Attunity Maestro, was included in Forrester's recent industry report, 'Market Overview - Application Release Automation Tools' (January 29, 2015). The report's author, Amy DeMartine, Senior Analyst, Infrastructure Operations, Forrester, will present the report's highlights in a free Attunity webinar this week entitled, 'Analyst Spotlight - Best Practices for Application Release Automation,' on Thursday, February 12, 2015, from 1:00 PM - 2:00 PM Eastern Time.
ATTU: 9.93 (+0.05)

Nasdaq stocks posting largest percentage decreases
AP - Thu Jan 29, 5:14PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
RDWR: 20.85 (+0.42), ESIO: 6.50 (+0.02), MCEP: 6.29 (+0.12), OTEX: 61.19 (+0.99), SSRI: 6.26 (+0.13), OTC.TO: 76.24 (+1.06), AREX: 8.15 (+0.27), SSO.TO: 7.81 (+0.16), EZPW: 9.96 (-0.29), WLB: 28.91 (+0.29), ATTU: 9.93 (+0.05), MITL: 10.33 (+0.12), XNCR: 15.47 (-0.22), FTNT: 33.23 (+0.25)

Attunity's (ATTU) CEO Shimon Alon on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Jan 29, 4:18PM CST

ATTU: 9.93 (+0.05)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Jan 29, 11:47AM CST

CRMD: 3.27 (+0.02), FRO: 2.96 (+0.07), NES: 3.52 (+0.13), SILC: 46.99 (+0.90), GNCA: 8.93 (-0.07), NBG: 1.61 (+0.18), APPY: 0.45 (-0.01), LRN: 16.56 (-0.06), SR: 1.25 (+0.08), DSKY: 11.99 (+0.14), GENE: 8.04 (+1.90), SMLR: 4.54 (+0.20), PFMT: 6.02 (-0.02), QCOM: 70.88 (+0.49), PSTR: 4.63 (+0.14), ENTL: 21.99 (+0.56), ATTU: 9.93 (+0.05), CTP: 6.53 (+0.13), LENS: 6.00 (-0.67), RCON: 2.11 (+0.15)

Attunity posts 4Q profit
Automated Insights - Thu Jan 29, 10:22AM CST
KFAR SABA, Israel (AP) _ Attunity Ltd. (ATTU) on Thursday reported fourth-quarter net income of $127,000, after reporting a loss in the same period a year earlier.
ATTU: 9.93 (+0.05)

Attunity misses by $0.03, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Jan 29, 6:09AM CST

ATTU: 9.93 (+0.05)

Attunity Reports 41% Revenue Growth In 2014
PR Newswire - Thu Jan 29, 6:00AM CST
Attunity, Ltd. (NASDAQ CM: ATTU), a leading provider of information availability software solutions, today reported its unaudited financial results for the three-month period and year ended December 31, 2014.
ATTU: 9.93 (+0.05)

Attunity Appoints David Collins as Vice President to Expand Sales and Revenues in Eastern North America
PR Newswire - Tue Jan 27, 6:00AM CST
Attunity Ltd. (NASDAQ CM: ATTU), a leading provider of information availability software solutions, announced today that it has appointed David Collins as Regional Vice President for Attunity's North American Sales Management team. In his new role, effective immediately, David is charged with leading sales efforts and driving sales growth for the eastern regions of the United States and Canada.
ATTU: 9.93 (+0.05), INTC: 34.36 (+0.23)

Attunity to Report Fourth Quarter 2014 and Full Year 2014 Results on January 29, 2015
PR Newswire - Thu Jan 15, 2:50PM CST
Attunity Ltd. (NASDAQ CM: ATTU), a leading provider of information availability software solutions, announced today that it will release its unaudited financial results for the three-month period and year ended December 31, 2014, on Thursday, January 29, 2015, before U.S. markets open.
ATTU: 9.93 (+0.05)

Attunity signs license agreement with cloud services company
M2 - Wed Jan 14, 7:58AM CST
Attunity Ltd (NASDAQ CM: ATTU) announced it has entered into a technology licensing agreement with a cloud services company that allows it to use Attunity's Replicate technology to facilitate data transfer between heterogeneous data environments and cloud-based systems and services.
ATTU: 9.93 (+0.05)

Attunity Announces Multi-Million Dollar, Strategic License Agreement with a Cloud Services Company
PR Newswire - Tue Jan 13, 6:00AM CST
Attunity Ltd. (NASDAQ CM: ATTU), a leading provider of information availability software solutions, announced today that it has entered into a multi-million dollar technology license agreement for Attunity Replicate with a Cloud Services Company, allowing it to use Attunity's replication and data transfer technology to facilitate data transfer between heterogeneous data environments and Cloud-based systems and services.
ATTU: 9.93 (+0.05)

Attunity: Well On Track To $100M In Revenues
Jonathan Fishman - at Seeking Alpha - Tue Jan 06, 2:31PM CST

ATTU: 9.93 (+0.05)

FireEye, Inc. (FEYE) in Focus: Stock Adds 7% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 22, 7:37AM CST
FireEye, Inc. (FEYE) was a big mover last session, as the company saw its shares rise almost 7% on the day
FEYE: 42.26 (+2.63), ATTU: 9.93 (+0.05)

Attunity (ATTU) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Dec 19, 9:12AM CST
Attunity (ATTU) Shares March Higher, Can It Continue?
ATTU: 9.93 (+0.05)

Weakness Seen in Sungy Mobile Limited (GOMO) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 7:32AM CST
One stock that you may want to consider dropping is Sungy Mobile Limited (GOMO), which has witnessed a significant price decline in the past four weeks
DTSI: 28.68 (+1.46), GOMO: 4.94 (+0.10), ATTU: 9.93 (+0.05)

Attunity Delivers On Big Data Growth In Q3: Future Looks Bright With Maestro, Hadoop And AWS
Galileo Russell - at Seeking Alpha - Fri Dec 12, 6:52AM CST

ATTU: 9.93 (+0.05)

j2 Global's Acquisitions and Inorganic Strength Hold Promise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 11:30AM CST
On Dec 9, 2014, we issued an updated research report on j2 Global Inc. (JCOM).
DTSI: 28.68 (+1.46), JCOM: 65.83 (+6.29), ATTU: 9.93 (+0.05), QLYS: 47.95 (+1.46)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 21

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 4

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 7

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Skiptown Expands in Georgia Amid Growing Demand

Updated Category News Views 24

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 25

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
Veterans Transitioning to Real Estate with Scholarships

Updated Category News Views 15

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 22

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
Omneky Outshines Competitors in AI Ad Scoring

Updated Category News Views 33

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 16

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Honeywell Aerospace Faces Legal Turbulence in Fraud Case

Updated Category News Views 7

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Continue Reading

Top 5 Most Recently Viewed Articles

Pieridae Energy Limited Reports Strong Q3 2024 Performance

Updated Category News Views 58

Strong Financial and Operational Results from Pieridae Energy CALGARY, Alberta - Pieridae Energy Limited (“Pieridae” or the “Company”) (TSX: PEA) has announced its third quarter 2024 financial and operating results, showcasing an impressive production output and robust financial performance. The company achieved a production rate of 23,116 barrels of oil...

Continue Reading
Atea Pharmaceuticals Showcases Promising HCV Treatment Data

Updated Category News Views 136

Innovation in Hepatitis C Treatment by Atea Pharmaceuticals Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) has made a significant impact in the field of antiviral therapeutics through their ongoing research and development efforts. The company recently presented compelling data at The Liver Meeting 2024, highlighting the promising combination of bemnifosbuvir and ruzasvir for...

Continue Reading
Study Confirms Safety of Combined Eye Drops for Surgery Use

Updated Category News Views 172

Introduction to the Study A five-year pharmacovigilance study has confirmed the excellent safety profile of a fixed-dose combination eye drop developed by NTC. This eye drop combines an anti-inflammatory steroid and a quinolone antibiotic, designed for preventing and treating inflammation, as well as preventing infection after cataract surgery. Study Overview The findings...

Continue Reading
New Concerns Arise for Roblox Amid Allegations of Misreported Metrics

Updated Category News Views 203

Allegations Against Roblox: A Closer Look Roblox Corp (NYSE: RBLX) has recently come under fire after a report from Hindenburg Research highlighted potential discrepancies in its reported user metrics, leading to a notable decline in its stock prices. The gaming platform is being questioned for allegedly overstating its user metrics, including daily active users (DAUs)...

Continue Reading
uniQure N.V. Faces Investigation Amid Securities Fraud Concerns

Updated Category News Views 155

Understanding the uniQure N.V. Investigation Currently, uniQure N.V. is under investigation concerning possible violations of securities laws. This inquiry has raised significant concerns for shareholders and potential investors, driving many to seek assistance in understanding their rights moving forward. The investigation is being led by the DJS Law Group, an...

Continue Reading